Welcome to our dedicated page for Gohealth SEC filings (Ticker: GOCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The GoHealth, Inc. (NASDAQ: GOCO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered tools to help interpret them. As a health insurance marketplace and Medicare-focused digital health company, GoHealth uses its filings to report financial results, capital structure changes, governance updates, and key operating metrics.
Core documents for GOCO include annual reports on Form 10-K and quarterly reports on Form 10-Q, where the company discusses its Medicare-focused marketplace model, non-GAAP measures such as EBITDA and Adjusted EBITDA, and operating metrics like Submissions, Sales per Submission, Direct Operating Cost of Submission, and Direct Operating Cost per Submission. These filings also contain sections such as “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which elaborate on the environment in which GoHealth operates.
GoHealth’s current reports on Form 8-K provide timely detail on material events. Recent 8-K filings describe the announcement of quarterly results, the entry into a superpriority senior secured term loan facility, amendments to the existing credit agreement, the issuance of Class A common stock to lenders, and changes in the composition of the board of directors, including the creation of a Transformation Committee. Other 8-Ks report annual meeting voting results and director appointments or resignations.
On this page, Stock Titan’s AI features summarize lengthy filings so users can quickly see what changed in each document, such as new financing terms, covenant adjustments, or governance provisions. Real-time updates from EDGAR ensure that newly filed 10-Ks, 10-Qs, and 8-Ks for GOCO appear promptly, while AI-generated highlights help explain complex credit agreement amendments, liquidity covenants, and board-level decisions.
For those examining GoHealth’s regulatory history, this filings page offers structured access to its SEC reports, including details on financial performance, capital structure, and corporate governance, supported by automated summaries that make dense legal and financial language easier to understand.
GoHealth, Inc. has filed a resale registration covering up to 9,566,028 shares of its Class A common stock. These shares may be sold from time to time by the selling stockholder, Centerbridge, using methods such as brokered trades, underwritten offerings, private sales, or other transactions at market or negotiated prices.
GoHealth is not selling any shares in this offering and will not receive any proceeds; Centerbridge will receive all sale proceeds and pay any underwriting discounts and selling commissions. The registered shares include 5,386,178 shares issuable upon exchange of GoHealth Holdings, LLC interests and cancellation of an equal number of Class B shares. GoHealth’s Class A stock trades on Nasdaq under the symbol “GOCO,” and 16,093,116 Class A shares were outstanding as of December 11, 2025.
GoHealth, Inc. has filed an amended shelf registration to allow selling stockholders to resell up to 12,026,489 shares of its Class A common stock from time to time. These shares include 7,260,270 shares held or issuable to pre‑IPO investors through exchanges of LLC Interests and 4,766,219 shares issued to certain lenders in connection with credit agreement amendments and a new superpriority credit facility. The company itself is not selling any shares in this registration and will receive no proceeds from these resales, while the selling stockholders will bear any underwriting discounts and selling commissions. GoHealth’s Class A stock trades on Nasdaq under the symbol “GOCO,” and 16,093,116 shares of Class A common stock were outstanding as of November 13, 2025. The filing also summarizes GoHealth’s multi‑class capital structure, Series A convertible preferred stock, and governance and anti‑takeover provisions.
GoHealth, Inc. has filed a shelf registration statement covering the resale of up to 4,766,219 shares of its Class A common stock by a group of lending institutions that received the shares in a private placement. The company is not selling any shares in this offering and will not receive proceeds from sales made by these selling stockholders, who will bear any underwriting discounts and commissions.
The registered shares were issued as consideration for lenders entering into an amendment to GoHealth’s existing credit agreement and a new superpriority senior secured “priming” credit facility, which also coincided with board changes and the creation of a Transformation Committee focused on strategic alternatives. As context, GoHealth had 16,093,116 shares of Class A common stock outstanding as of November 13, 2025, and its Class A stock trades on Nasdaq under the symbol “GOCO”.
GoHealth, Inc. reported a sharp downturn for the quarter ended September 30, 2025. Net revenues were $34,186 thousand, and the company recorded a net loss of $313,918 thousand, driven by $206,163 thousand in impairment charges on indefinite and long‑lived assets. Operating expenses climbed to $322,103 thousand, resulting in a loss from operations of $287,917 thousand.
Liquidity and leverage were central themes. GoHealth amended its credit facilities and entered a Superpriority Senior Secured Credit Agreement totaling $115.0 million (including $80.0 million new‑money and $35.0 million roll‑up term loans) and issued 4,766,219 Class A shares to lenders tied to Amendment No. 14. Long‑term debt (net) rose to $581,844 thousand, and the company ended the quarter with cash of $32,076 thousand. Nine‑month operating cash flow was an outflow of $82,873 thousand.
Management disclosed a significant likelihood of failing to maintain covenant compliance within 12 months absent mitigating actions, and initiated cost measures including a Q4 2025 workforce reduction of approximately 487 employees. As of November 6, 2025, shares outstanding were 16,093,116 Class A and 12,620,884 Class B.
GoHealth, Inc. filed a current report to let investors know it has released its latest quarterly financial results. On November 13, 2025, the company issued a press release announcing results for the quarter ended September 30, 2025, and furnished that press release as Exhibit 99.1 to this report. The company notes that this earnings information is being furnished rather than filed, which means it is not automatically subject to certain Exchange Act liabilities or incorporated into other securities filings unless specifically referenced.
GoHealth (GOCO) reported an insider transaction by its Chief Financial Officer on a Form 4. On 11/01/2025, the CFO had 12,725 shares of Class A common stock withheld at $3.96 per share, coded F, to satisfy tax withholding obligations tied to the vesting of 50,000 restricted stock units granted on November 1, 2024.
Following this transaction, the officer beneficially owns 237,275 shares directly. The filing reflects tax-related share withholding upon RSU vesting rather than an open-market sale.
GoHealth insider tax-withholding sale tied to RSU vesting. Mike Hargis, the company's Chief Operating Officer, reported a sale of 5,545 shares of Class A common stock on 09/12/2025 at a price of $4.98 per share. The filing states these shares were withheld by the company to satisfy tax withholding obligations related to the vesting of 22,222 restricted stock units granted on 09/12/2022. After the withholding, Hargis beneficially owns 324,993 shares directly. The form indicates the transaction was reported by a single reporting person and executed through an attorney-in-fact.
Mark Robert Weinstein, listed at the Chicago address on the form, filed an Initial Statement of Beneficial Ownership (Form 3) reporting his relationship to GoHealth, Inc. (GOCO) as a Director. The event date shown is 08/19/2025. The filing states no securities are beneficially owned and notes the Form was submitted late due to delays obtaining the reporting person’s EDGAR codes. The filing includes Exhibit 24 (Power of Attorney) and is signed on behalf of the reporting person by an attorney-in-fact on 09/02/2025. The filing was made by one reporting person.
Form 3 filed for GoHealth, Inc. (GOCO) reports that Truong Bao Dinh, identified as a Director, had no securities beneficially owned as of the event date
GoHealth, Inc. reported several changes to its Board of Directors. On August 19, 2025, the Board appointed Mark Weinsten as a Class II director, with a term running until the 2028 annual stockholders’ meeting. He is a managing director in BRG Corporate Finance and will receive a monthly cash retainer of $25,000, pro-rated for his first partial month, plus reimbursement of certain expenses.
The Board also appointed Bao Truong, a senior managing director at Centerbridge Partners, L.P., as a Class III director with a term expiring at the 2026 annual stockholders’ meeting. He joined the Transformation Committee, Compensation Committee, and Nominating and Corporate Governance Committee and, as a Centerbridge employee, will not receive Board compensation. Both new directors entered into GoHealth’s standard director indemnification agreements, and each was nominated as a Centerbridge designee under a 2020 Stockholders Agreement.
On the same date, Centerbridge designees Jeremy W. Gelber and Abhiraj Modi resigned from the Board. The company stated their resignations did not result from any disagreement regarding operations, policies, or practices.